bioMérieux S.A. - Laporan Laba Rugi (TTM)

bioMérieux S.A.
AT ˙ WBAG ˙ FR0013280286
€ 120.50 ↑0.60 (0.50%)
2025-07-10
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi bioMérieux S.A. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 2,997 3,118 3,167 3,216 3,296 3,376 3,418 3,460 3,525 3,589 3,645 3,701 3,688 3,675 3,741 3,806 3,893 3,980 4,051 4,122
Change (%) 4.04 1.57 1.55 2.49 2.43 1.24 1.23 1.87 1.83 1.56 1.54 -0.36 -0.36 1.79 1.76 2.28 2.23 1.78 1.75
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,334 1,364 1,362 1,358 1,367 1,375 1,408 1,442 1,511 1,580 1,606 1,631 1,624 1,617 1,652 1,686 1,725 1,765 1,784 1,802
Change (%) 2.31 -0.22 -0.22 0.62 0.62 2.41 2.35 4.81 4.59 1.61 1.58 -0.43 -0.43 2.11 2.06 2.34 2.29 1.07 1.06
% of Revenue 44.50 43.76 42.99 42.24 41.47 40.74 41.21 41.66 42.87 44.03 44.05 44.07 44.04 44.01 44.15 44.28 44.31 44.34 44.03 43.73
Gross Operating Profit 1,663 1,754 1,806 1,858 1,929 2,001 2,010 2,018 2,014 2,009 2,039 2,070 2,064 2,057 2,089 2,121 2,168 2,215 2,267 2,319
Change (%) 5.43 2.97 2.88 3.85 3.71 0.44 0.44 -0.24 -0.24 1.52 1.50 -0.30 -0.31 1.55 1.52 2.23 2.18 2.35 2.30
% of Revenue 55.50 56.24 57.01 57.76 58.53 59.26 58.79 58.34 57.13 55.97 55.95 55.93 55.96 55.99 55.85 55.72 55.69 55.66 55.97 56.27
SG&A 784 789 788 786 801 816 846 877 916 955 986 1,016 1,018 1,020 1,038 1,055 1,076 1,098 1,114 1,130
Change (%) 0.73 -0.22 -0.22 1.90 1.86 3.78 3.64 4.42 4.23 3.24 3.14 0.20 0.20 1.67 1.64 2.04 2.00 1.49 1.46
% of Revenue 26.14 25.31 24.87 24.43 24.29 24.16 24.76 25.35 25.99 26.60 27.04 27.46 27.62 27.77 27.74 27.71 27.64 27.58 27.50 27.42
R&D 399 399 388 377 381 386 399 412 429 447 456 466 463 460 467 474 483 492 496 500
Change (%) 0.05 -2.76 -2.84 1.19 1.18 3.41 3.30 4.19 4.02 2.15 2.10 -0.61 -0.62 1.55 1.53 1.80 1.77 0.87 0.87
% of Revenue 13.30 12.79 12.24 11.72 11.57 11.43 11.67 11.91 12.18 12.44 12.52 12.59 12.55 12.52 12.49 12.46 12.40 12.35 12.24 12.13
OpEx 2,469 2,506 2,491 2,476 2,519 2,563 2,634 2,706 2,841 2,976 3,058 3,139 3,122 3,106 3,163 3,220 3,281 3,342 3,453 3,564
Change (%) 1.48 -0.59 -0.60 1.75 1.72 2.79 2.71 5.00 4.76 2.74 2.67 -0.54 -0.54 1.84 1.81 1.89 1.86 3.31 3.21
% of Revenue 82.38 80.36 78.64 76.98 76.43 75.90 77.06 78.19 80.60 82.92 83.88 84.82 84.67 84.52 84.55 84.59 84.28 83.97 85.24 86.45
Operating Income 528 612 676 740 777 814 784 754 684 613 587 562 565 569 578 586 612 638 598 558
Change (%) 16.01 10.43 9.45 4.94 4.71 -3.63 -3.76 -9.38 -10.35 -4.17 -4.35 0.63 0.63 1.54 1.51 4.38 4.20 -6.24 -6.65
% of Revenue 17.62 19.64 21.36 23.02 23.57 24.10 22.94 21.81 19.40 17.08 16.12 15.18 15.33 15.48 15.45 15.41 15.72 16.03 14.76 13.55
Interest Expense -21 -25 -23 -20 -15 -9 -10 -10 -8 -4 -4 -3 -9 -16 -4 -4 -16 -16 -16 -15
Change (%) 16.36 -8.84 -9.69 -27.80 -38.51 6.59 6.19 -26.21 -46.05 -10.98 -12.33 184.38 73.63 -74.68 -10.00 330.56 3.23 -3.12 -3.23
% of Revenue -0.71 -0.80 -0.72 -0.64 -0.45 -0.27 -0.28 -0.30 -0.22 -0.11 -0.10 -0.09 -0.25 -0.43 -0.11 -0.09 -0.40 -0.40 -0.38 -0.36
Net Income 355 404 456 509 555 601 577 552 502 452 419 386 372 358 384 411 422 432 405 378
Change (%) 14.00 12.88 11.41 9.09 8.34 -4.08 -4.25 -9.03 -9.93 -7.35 -7.93 -3.67 -3.81 7.51 6.98 2.54 2.48 -6.28 -6.70
% of Revenue 11.84 12.97 14.41 15.81 16.83 17.80 16.87 15.96 14.25 12.60 11.50 10.43 10.08 9.73 10.28 10.81 10.83 10.86 10.00 9.17

Source: Capital IQ

Other Listings
FR:BIM € 118.30
GB:0RUG € 118.05
US:BMXMF
GB:BIMP
DE:EYWN € 115.60
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista